Welcome to our dedicated page for Pediatrix Medical Group SEC filings (Ticker: MD), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Looking for the numbers behind every neonatal intensive-care shift or wondering how physician reimbursement shapes Pediatrix Medical Group鈥檚 margins? This page gathers every SEC disclosure so you can move from question to answer without wading through hundreds of pages.
Start with the Pediatrix Medical Group quarterly earnings report 10-Q filing to trace NICU volume trends or payer-mix shifts. Need a full picture? The Pediatrix Medical Group annual report 10-K simplified by Stock Titan鈥檚 AI highlights malpractice reserve changes and hospital contract renewals in plain English鈥攏o medical jargon required.
Curious about executive incentives for quality outcomes? The Pediatrix Medical Group proxy statement executive compensation section pinpoints bonus metrics tied to neonatal survival rates. Wondering whether insiders are buying shares after a contract win? Our real-time alerts flag Pediatrix Medical Group insider trading Form 4 transactions within minutes of EDGAR release, complete with AI context.
- Instant summaries translate complex CPT billing tables into straightforward revenue drivers.
- Form 8-K material events鈥攖hink major hospital agreements鈥攁re explained in a single paragraph so you can judge impact fast.
- Side-by-side comparisons let you track segment operating margins across quarters.
Whether you search 鈥渦nderstanding Pediatrix Medical Group SEC documents with AI鈥� or 鈥淧ediatrix Medical Group Form 4 insider transactions real-time,鈥� this hub delivers. Every filing鈥�10-K, 10-Q, 8-K, Form 4鈥攊s auto-indexed, time-stamped and accompanied by concise analysis. Spend less time decoding regulatory language and more time evaluating how Pediatrix鈥檚 specialized physician model affects future cash flows.
Pediatrix Medical Group insider transfer disclosure. Thomas McEachin, a director, reported transfers of common stock on August 19 and August 20, 2025. The filings show 54,021 shares were transferred on August 19, 2025, and 625 shares on August 20, 2025, each reported as dispositions at $0. After the transactions the report lists 11,427 shares held directly and 54,646 shares held indirectly by the Thomas A. McEachin Living Trust dated April 17, 2025. The Form 4 was executed by an attorney-in-fact and signed on August 21, 2025. The reporting person and spouse are identified as trustees and beneficiaries of the trust that holds the reported securities.
FAQ
What is the current stock price of Pediatrix Medical Group (MD)?
What is the market cap of Pediatrix Medical Group (MD)?
